Ningxia Qiyuan Pharmaceutical Co.,Ltd is consolidated from former Ningxia Pharmaceutical Factory and Ningxia Traditional Chinese Medicine Factory. With the new operation system, high-efficiency in production and management, strong ability for product innovation, the company has been developed to one of the predominant enterprise in the nation??s pharmaceutical industry. The company is recognized as the emphasized hi-tech enterprise by the national science bureau and the national foreign trade and economic cooperation bureau. It is also one of the hundred emphasized hi-tech export enterprises. It??s leading product---Tetracycline hydrochloride bulk drugs owns 70% world market share, with superior quality, largest manufacture scale in the world and advanced technology it enjoys great popularity in the world. The product is exported to Europe, South America, Africa, South-east Asia, and many other countries and districts etc. As an integrated pharmaceutical enterprise in west China, QIYUAN has a diversified manufacture scope close to 300 products, including bulk drugs, tablets, pills, granules, capsules, powder for injections, infusions, suppositories etc. All the manufacturing workshops have get the nation??s GMP authentication. The company has advanced facilities and instruments, well-established quality assurance system and perfect after-service. ??QIYUAN?? is a famous brand in the market. The company has sales branches in the large and medium-sized cities such as Beijing, Shanghai, Nanjing, Chendu, Guangzhou, Xi??an etc. QIYUAN always follows the motto of ??Base on honesty and credibility, Priority to high efficiency??. Ningxia has rich coal resource and power energy, the cost is lower than any other regions in China and in the world. The dry climate here is very suitable for fermentation. With the implement of central government??s strategy of western development, the company can enjoy more and more privileged policies. Besides we have accumulated rich experiences in fermentation during manufacturing of bulk drug Tetracycline Hydrochloride. Based on captioned advantages, QIYUAN has full confidence in producing another competitive product and base itself upon the world pharmaceutical market. Now the company is establishing a biology pharmaceutical park in Wanyuan economic developing district (located in Yinchuan). It covers the area of 800,000m2. It will be mainly for the production of bulk drugs, including Erythromycin series products with annual output 2000ton and Tetracycline Hydrochloride with total annual output 4000ton. The total investment will be 560million RMB. The QIYUAN Biology Pharmaceutical Park will be put into production in July 2004. By then it will settle a stable foundation for the company??s lasting development. QIYUAN's target is to establish good reputation in the world, care for people??s health, serve for the society and make contribution to mankind. We sincerely hope to cooperate with friends in every circle by means of investment, sales cooperation or technical cooperation etc, to make a prosperous future together.
As an integrated pharmaceutical enterprise in west China, QIYUAN has a diversified manufacture scope close to 300 products, including bulk drugs, tablets, pills, granules, capsules, powder for injections, infusions, suppositories etc.